Your search history is turned on.
Date: April 10, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - NeuPath-BBHIC-PR-Apr10.2024.final NEUPATH HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE TORONTO, ONTARIO, April 10, 2024 NeuPath Health Inc. (TSXV:NPTH), (NeuPath or the Company), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph ...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: NEUPATH HEALTH INC. Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual General and Special Meeting of Securi...
Date: March 15, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, ZYGOURAS, Jeff, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonabl...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Date: March 15, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - NeuPath Annual Information Form-YE2023.March14.final ANNUAL INFORMATION FORM FOR THE YEAR ENDED DECEMBER 31, 2023 March 14, 2024 TABLE OF CONTENTS NOTE TO READER ..........................................................................................................................
Microsoft Word - NeuPath Health Inc. - CFO Annual Certificate - YE 2023(422685531.1) FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Jeff Zygouras, Chief Financial Officer of NeuPath Health Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, inclu...
Microsoft Word - NeuPath Health Inc. - CEO Annual Certificate - YE 2023(422687251.1) FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Joseph Walewicz, Chief Executive Officer of NeuPath Health Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, inc...
Microsoft Word - NeuPath-Q4-2023-MDA-Mar14.final Page | 1 Managements Discussion and Analysis March 14, 2024 / This Managements Discussion and Analysis of the Financial Position and Results of Operations (MD&A) is the responsibility of management and has been reviewed and approved by the Board of Directors. This MD&A has been prepared in accordance w...
Microsoft Word - NeuPath-Q4-2023-FS-Mar14.final NeuPath Health Inc. Consolidated Financial Statements December 31, 2023 and 2022 (audited) NeuPath Health Inc. Consolidated Financial Statements (audited) P a g e | 2 INDEPENDENT AUDITORS REPORT To the Shareholders of NeuPath Health Inc. Opinion We have audited t...
Microsoft Word - NeuPath-Q4-2023-PR-Mar15.final NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2023 RESULTS Fourth quarter total revenue of $16.8 million, up 4% year-over-year Adjusted EBITDA(1) of $0.8 million, our 20th consecutive quarter of positive adjusted EBITDA Improved cash flows, closing cash and cash equivalents balance of $3.2 m...